Key insights and recommendations.


Navigating the US payer landscape and the evolving influence of ICER

Free download

Dear Colleague,

Securing optimal reimbursement and patient access in the US is complex – and it’s likely to become even more complex over the months and years to come.

Here’s the good news: market access success doesn’t have to stretch your budgets or create more work. A great place to reinvigorate your thinking is this collection of landmark studies on the US payer landscape and the evolution of ICER’s influence:


This free collection of research and recommendations will help you:

  • appreciate how changing US payer decision-making priorities may affect the pricing and reimbursement of your products
  • understand the evolving impact of ICER evaluations for your market access strategies
  • learn how technology is helping leading manufactures to unlock product value from early development through to successful commercialization.

Don’t jeopardize your US market access and commercial potential – read the research today and get in touch with us for a confidential conversation about your current challenges and PRMA Consulting’s solutions.


Nathan White
CPC Senior Principal & US Practice Lead


Linea House,

Harvest Crescent,

Fleet, Hampshire,

GU51 2UZ. UK


UK +44 (0)1252 786284
US +1 (415) 655 6798
Company number: 05893400

This email was sent on behalf of the sponsor by HealthEconomics.Com, 1327 Walnut, Jacksonville, FL, 32206.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above.
Read more about our privacy policy here. You may also request a copy in writing using the address above.

To ensure you continue to receive emails from HealthEconomics.Com, please click here.